PHBI

NeoRich BioPharma Tech Co., Limited Stock Price

OTCPK:PHBI.D Community·US$345.7k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PHBI.D Share Price Performance

US$0.90
-0.90 (-50.00%)
US$0.90
-0.90 (-50.00%)
Price US$0.90

PHBI.D Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

NeoRich BioPharma Tech Co., Limited Key Details

US$3.0k

Revenue

US$1.7k

Cost of Revenue

US$1.3k

Gross Profit

US$227.6k

Other Expenses

-US$226.3k

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About PHBI.D

Founded
n/a
Employees
n/a
CEO
Peter Wojcik
WebsiteView website
www.pharmagreen.ca

NeoRich BioPharma Tech Co., Limited operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company’s primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. The company was formerly known as Pharmagreen Biotech Inc. and changed its name to NeoRich BioPharma Tech Co., Limited in April 2026. The company is headquartered in Coquitlam, Canada.

Recent PHBI.D News & Updates

Recent updates

No updates